State Of Wyoming Eli Lilly & CO Transaction History

State Of Wyoming

$587 Million
Q1 2024

A detailed history of State Of Wyoming transactions in Eli Lilly & CO stock. As of the latest transaction made, State Of Wyoming holds 904 shares of LLY stock, worth $819,665. This represents 0.12% of its overall portfolio holdings.

Number of Shares

904

Previous 929 2.69%

Holding current value

$819,665

Previous $541,000 29.94%

% of portfolio

0.12%

Previous 0.1%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $14,805 - $19,807	-25 Reduced 2.69%	904 $703,000
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $160,708 - $189,453	306 Added 49.12%	929 $541,000
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $4,347 - $5,993	-10 Reduced 1.58%	623 $334,000
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $221,667 - $296,395	632 Added 63200.0%	633 $296,000
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $358,467 - $421,002	-1,154 Reduced 99.91%	1 $0

Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $371,068 - $432,369	1,154 Added 115400.0%	1,155 $422,000
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $186,485 - $212,520	-629 Reduced 99.84%	1 $0
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $203,751 - $239,234	-731 Reduced 53.71%	630 $204,000
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $120,395 - $149,621	513 Added 60.5%	1,361 $390,000
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $449 - $558	-2 Reduced 0.24%	848 $234,000
Q3 2021 Feb 11, 2022	BUY	$221.6 - $272.71 $111,021 - $136,627	501 Added 143.55%	850 $196,000
Q2 2021 Feb 11, 2022	SELL	$180.55 - $233.54 $98,038 - $126,812	-543 Reduced 60.87%	349 $80,000
Q1 2021 Feb 08, 2022	BUY	$164.32 - $212.72 $146,573 - $189,746	892 New	892 $167,000

Others Institutions Holding LLY

# of Institutions

3,721

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $862B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.

Account